EVAXION BIOTECH A/S (EVAX)

US29970R2040 - ADR

1.06  +0.21 (+25.3%)

After market: 1.08 +0.02 (+1.89%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
3.29M73.00K0.000.000.00
Operating Expenses
18.37M22.27M25.26M25.83M16.57M
Research and Development
10.50M11.58M17.04M19.61M11.61M
Selling, General, and Administrative Expenses
7.87M10.08M8.07M6.18M5.65M
Operating Income
-15.07M-22.20M-25.26M-25.83M-16.57M
Interest Income/Expense
2.91M-718.00K1.32M1.12M-7.00K
Income Before Taxes
-12.15M-22.91M-23.94M-24.71M-16.57M
Income Tax
-690.00K-790.00K-772.00K-178.00K-1.56M
Net Income
-11.46M-22.13M-23.17M-24.53M-15.02M
EBITDA
N/A-21.58M-24.69M-25.49M-16.46M
 
Per Share Data
EPS Diluted Total Ops
-15.83-76.20-92.31-118.50-74.70
Non GAAP EPS
-1.46-8.20-9.80-12.50N/A
 
Statistics
Profit Margin
-347.86%-30308.22%N/AN/AN/A
Operating Profit Margin
-457.42%-30406.85%N/AN/AN/A

All data in USD

Charts